The 7th Annual MarketsandMarkets High Potent Medicines Conference to be held on 25th – 26th May 2022 and we’ll be there
One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations.
Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.
This conference will be addressing the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
Key areas for discussion will include:
- Process Development and scale up of HPAPI’s
- Strategies for effective outsourcing partnership
- Containment and Handling Strategies
- Validation of cleaning procedures to avoid cross-contamination
- Regulatory Landscape
- Hazard Assessment Classifications
David O’Connell, Director of Scientific Affairs will be speaking in session one of the event, join him at 9:10 am for a discussion around Key considerations when choosing the right CDMO for the development and manufacturing of drug products containing HPAPI.
Jerome Detreille, Yannick Vuillamy and Matt Tyler will also be available throughout the event to discuss your CDMO requirements
For more information or to register for this event, please see the event website
Event: 7th Annual MarketsandMarkets High Potent Medicines Conference
Date: 25-26 May 2022
Where: Renaissance London Heathrow Hotel - Marriott
Country: United Kingdom